Wall Street Associates’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-6,455
Closed -$724K 265
2015
Q4
$724K Sell
6,455
-200
-3% -$22.4K 0.2% 166
2015
Q3
$641K Buy
+6,655
New +$641K 0.12% 198
2014
Q3
Sell
-8,700
Closed -$391K 330
2014
Q2
$391K Sell
8,700
-400
-4% -$18K 0.03% 285
2014
Q1
$445K Buy
+9,100
New +$445K 0.04% 273